Plaintiffs from Bismarck, North Dakota are suing drug maker GlaxoSmithKline based on allegations that their medication Zofran caused the claimants’ son to be born with severe birth defects. According to the suit, had the plaintiffs known the truth about Zofran’s “unreasonable risk of harm, long... Read More

GlaxoSmithKline (GSK), the manufacturer of an anti-nausea drug at the center of controversy over the harm it allegedly causes developing fetuses, has filed a motion to centralize all Zofran lawsuits alleging birth defects before one judge. The manufacturer has petitioned for the establishment of a federal... Read More

A Bergen County mother and father have filed suit in the United States District Court for the District of Jersey in what may be the very latest in the growing tally of lawsuits stemming from the use of anti-nausea medication Zofran (ondansetron) by pregnant women... Read More

Parents have filed a Zofran heart defects lawsuit in Ohio against GlaxoSmithKline, alleging use of their anti-nausea drug during pregnancy led to the severe heart defects and subsequent death of their daughter. The plaintiffs are seeking damages from the pharmaceutical giant, stating the company failed... Read More

The Saint Louis Dispatch recently reported on a landmark verdict involving the anti-seizure drug Depakote and birth defects. The case, which was tried in a St. Louis Circuit Court before Judge Steven Ohmer, argued that the anti-epileptic medication caused the plaintiff’s now 12-year old daughter... Read More

The U.S. District Court for the Eastern District of Arkansas is now the scene of yet another Zofran lawsuit, adding to the growing tally of birth defect complaints being filed across the country. On May 21, a couple residing in that state formally alleged that... Read More

This summer, health regulators at the FDA will hold a meeting to address the legalities of off-label drug promotion by pharmaceutical companies. Any medications that are prescribed for unapproved uses that have not been clinically demonstrated as safe and effective are considered “off-label.” According to... Read More

Two new Zofran lawsuits allege that GlaxoSmithKline (GSK) engaged in fraudulent marketing practices relating to use of the medication as an off-label treatment for morning sickness. The plaintiffs, filing in Texas and Massachusetts federal courts respectively, argue that the pharmaceutical company misled the public about... Read More